JP2023546766A5 - - Google Patents
Info
- Publication number
- JP2023546766A5 JP2023546766A5 JP2023502590A JP2023502590A JP2023546766A5 JP 2023546766 A5 JP2023546766 A5 JP 2023546766A5 JP 2023502590 A JP2023502590 A JP 2023502590A JP 2023502590 A JP2023502590 A JP 2023502590A JP 2023546766 A5 JP2023546766 A5 JP 2023546766A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- acid sequence
- cdr1
- cdr2
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2020102470 | 2020-07-16 | ||
| CNPCT/CN2020/102470 | 2020-07-16 | ||
| PCT/CN2021/106889 WO2022012681A1 (en) | 2020-07-16 | 2021-07-16 | Multispecific chimeric antigen receptors and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023546766A JP2023546766A (ja) | 2023-11-08 |
| JP2023546766A5 true JP2023546766A5 (https=) | 2024-07-11 |
Family
ID=79554495
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023502590A Pending JP2023546766A (ja) | 2020-07-16 | 2021-07-16 | 多重特異性キメラ抗原受容体及びその使用 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20230257475A1 (https=) |
| EP (1) | EP4182356A4 (https=) |
| JP (1) | JP2023546766A (https=) |
| KR (1) | KR20230040333A (https=) |
| CN (1) | CN116390941A (https=) |
| AU (1) | AU2021308745A1 (https=) |
| CA (1) | CA3189531A1 (https=) |
| IL (1) | IL299865A (https=) |
| WO (1) | WO2022012681A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7846667B2 (ja) * | 2020-07-16 | 2026-04-15 | レジェンド バイオテック アイルランド リミテッド | Ｃｄ２０結合分子及びその使用 |
| CN114478803B (zh) * | 2022-02-11 | 2023-09-26 | 北京大学深圳研究生院 | 一种新型双特异性嵌合抗原受体的构建及其应用 |
| WO2024173607A2 (en) * | 2023-02-14 | 2024-08-22 | Evolveimmune Therapeutics, Inc. | Combination of bispecific antibodies and chimeric antigen receptor t cells for treatment |
| WO2025049972A1 (en) * | 2023-09-01 | 2025-03-06 | Cargo Therapeutics, Inc. | Compositions and methods for immunotherapies |
| WO2025146143A1 (zh) * | 2024-01-05 | 2025-07-10 | 南京传奇生物科技有限公司 | 治疗自身免疫疾病的方法 |
| WO2025214438A1 (zh) * | 2024-04-10 | 2025-10-16 | 浙江纳米抗体技术中心有限公司 | 结合cd19和/或cd22的抗原结合分子及其用途 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0624500D0 (en) * | 2006-12-07 | 2007-01-17 | Istituto Superiore Di Sanito | A novel passive vaccine for candida infections |
| JP2015524255A (ja) * | 2012-07-13 | 2015-08-24 | ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア | 二重特異性抗体を共導入することによってｃａｒｔ細胞の活性を強化する方法 |
| CA2874083C (en) * | 2014-12-05 | 2024-01-02 | Universite Laval | Tdp-43-binding polypeptides useful for the treatment of neurodegenerative diseases |
| WO2018028647A1 (en) * | 2016-08-10 | 2018-02-15 | Legend Biotech Usa Inc. | Chimeric antigen receptors targeting bcma and methods of use thereof |
| CN105384825B (zh) * | 2015-08-11 | 2018-06-01 | 南京传奇生物科技有限公司 | 一种基于单域抗体的双特异性嵌合抗原受体及其应用 |
| EP3426278B1 (en) * | 2016-03-07 | 2024-01-03 | Vib Vzw | Cd20 binding single domain antibodies |
| EP3774919A4 (en) * | 2018-03-30 | 2021-12-29 | Eureka Therapeutics, Inc. | Constructs targeting cd22 and uses thereof |
| SG11202104180WA (en) * | 2018-10-30 | 2021-05-28 | Peter Maccallum Cancer Inst | Bispecific polypeptides for engagement of car expressing immune cells with antigen presenting cells and uses thereof |
| CN111217908B (zh) * | 2019-11-29 | 2021-07-06 | 深圳普瑞金生物药业有限公司 | Cd22单域抗体、核苷酸序列、试剂盒、car-t病毒载体及car-t细胞 |
| CN110922482B (zh) * | 2019-12-25 | 2021-08-31 | 源道隆（苏州）医学科技有限公司 | 可结合cd19的多肽及其应用 |
-
2021
- 2021-07-16 IL IL299865A patent/IL299865A/en unknown
- 2021-07-16 WO PCT/CN2021/106889 patent/WO2022012681A1/en not_active Ceased
- 2021-07-16 EP EP21842411.7A patent/EP4182356A4/en active Pending
- 2021-07-16 KR KR1020237001635A patent/KR20230040333A/ko active Pending
- 2021-07-16 CN CN202180061010.4A patent/CN116390941A/zh active Pending
- 2021-07-16 JP JP2023502590A patent/JP2023546766A/ja active Pending
- 2021-07-16 US US18/015,505 patent/US20230257475A1/en active Pending
- 2021-07-16 CA CA3189531A patent/CA3189531A1/en active Pending
- 2021-07-16 AU AU2021308745A patent/AU2021308745A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023546766A5 (https=) | ||
| JP2023546764A5 (https=) | ||
| JP2025028239A5 (https=) | ||
| US20220267438A1 (en) | Trispecific antibody targeting bcma, gprc5d, and cd3 | |
| TWI781098B (zh) | 新穎的ｂ７-ｈ３-結合分子、其抗體藥物綴合物及其使用方法 | |
| JP2023051968A (ja) | 多重特異的ＮＫｐ４６結合タンパク質 | |
| FI3334765T3 (fi) | Yksidomeenivasta-aineisiin perustuvia kimeerisiä antigeenireseptoreita ja menetelmiä niiden käyttämiseksi | |
| KR20230143177A (ko) | 신규한 항-cd24 항체 | |
| JP2019537433A5 (https=) | ||
| JP2022542543A5 (https=) | ||
| JP2023524997A5 (https=) | ||
| JP2021526844A5 (https=) | ||
| JP2022513682A5 (https=) | ||
| JP2024537772A5 (https=) | ||
| US20250270315A1 (en) | Novel anti-sirpa antibodies | |
| WO2022147222A1 (en) | Antibodies to tnfr2 and uses thereof | |
| KR20250021334A (ko) | 신규 항-gprc5d 항체, gprc5d와 cd3에 결합하는 이중특이적 항원 결합 분자, 및 이들의 용도 | |
| CA3258731A1 (en) | NEW ANTI-LIRB4 ANTIBODIES AND THEIR USES | |
| JP2023546765A5 (https=) | ||
| WO2024041315A1 (en) | Novel anti-lilrb2 antibodies and uses thereof | |
| JP7503215B2 (ja) | Ｃｄ３０及びｃｄ３に結合する抗体 | |
| JP2023554467A5 (https=) | ||
| EA052500B1 (ru) | Новые антитела против cd24 | |
| HK40112412A (zh) | 与cd137和肿瘤相关抗原结合的双特异性结合蛋白 | |
| KR20250108115A (ko) | 신규 다중특이적 항체 및 이의 용도 |